The Down-Low on Drug Pricing

Understanding US drug pricing can feel like a fool’s errand—Axios took a stab at it.

While the US spends more on hospital care and doctor visits than prescription drugs, one drug's price can tip the spending scales—like hepatitis C treatments that sent spending spiraling in 2014.
Prices can even vary wildly patient from patient, and insurance plans’ pricing structures are top secret. Middle men who negotiate for insurance companies work on commission, sparking criticism that they benefit from high drug prices. Meanwhile, the leading pharma lobby has already spent tens of millions of dollars defending their stance in Washington this year.


Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top